Privia Health
PRVA
191 hedge funds and large institutions have $1.83B invested in Privia Health in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 52 reducing their positions, and 44 closing their positions.
73% more call options, than puts
Call options by funds: $14.7M | Put options by funds: $8.51M
58% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 52
0.21% less ownership
Funds ownership: 70.86% → 70.64% (-0.21%)
6% less funds holding
Funds holding: 203 → 191 (-12)
23% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 44
30% less capital invested
Capital invested by funds: $2.62B → $1.83B (-$788M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$54.9M |
| 2 |
Millennium Management
New York
|
+$54M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$21.7M |
| 4 |
BlackRock
New York
|
+$17.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$88.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$24M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$19.2M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$8.81M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$7.18M |
PRVA Hedge Fund Activity: Q4 2022 in Review
191 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q4 2022, worth a combined $1.83B — down 30% from $2.62B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of PRVA and 34 opened new positions — a net loss of 10 holders — while 52 trimmed existing stakes and 82 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $54.9M. The largest seller was Goldman Sachs, cutting an estimated $88.7M.
- 191 institutional investors held Privia Health (PRVA) as of Q4 2022, down from 203 in Q3 2022.
- Funds reported $1.83B of Privia Health stock for Q4 2022, down 30% quarter-over-quarter.
- 34 funds opened new Privia Health positions in Q4 2022 and 44 closed out, a net change of -10 holders.
- The largest Privia Health buyer in Q4 2022 was Point72 Asset Management, an estimated $54.9M added.
- The largest Privia Health seller in Q4 2022 was Goldman Sachs, an estimated $88.7M sold.
Based on aggregated 13F filings for Q4 2022.